Affordable Access

Publisher Website

964-11 Circadian Variation of Ventricular Arrhythmias is of Importance for Effective Drug Therapy

Authors
Journal
Journal of the American College of Cardiology
0735-1097
Publisher
Elsevier
Publication Date
Volume
25
Issue
2
Identifiers
DOI: 10.1016/0735-1097(95)92374-e
Disciplines
  • Medicine

Abstract

With regard to the restrictive and safe use of class I-antiarrhythmics (AA) clinical criteria predicting drug efficacy and safety have become important. In 140 pts (102 men, 63 ± 7 years) with frequent and symptomatic, but not life-threatening arrhythmias (VA; > 30/h) occurrence, reproducibility and therapeutic consequences of a circadian distribution (CD) of single/repetitive VA was studied. Pts underwent 3 24 h-Holter recordings at baseline, after 2 weeks of placebo and after 6 weeks of dose-titrated antiarrhythmic therapy. 67/140 pts (48%) had reproducible day-night CD (daytime VA increase: 50/67 pts, 75%). In Cox's regression analysis CD was characteristic of a lower VA rate (p < 0.05), but more frequent tachycardia episodes (risk: 3.8 times, p < 0.05) and a lower ejection fraction. AA response was better in pts with CD (3.3 times, p < 005). Day-/night CD pattern was also predictive for a superior response of class IA or IC agents (Fig.). In conclusion CD of VA is common in half of the pts with symptomatic VA. When class I agents are used. CD provides clinical evidence for selection of the most effective AA and dose and may help to improve overall antiarrhythmic benefit.

There are no comments yet on this publication. Be the first to share your thoughts.